ABHD11 and non-small cell lung carcinoma: For example, in non-small-cell lung cancer, MeRIP-Seq discovers that there was a m6A modification site in ABHD11-AS1 and METTL3 promotes the ABHD11-AS1 transcript stability to increase its expression [26].